ArticleEpilepsia open2025
Associations between the gut microbiota, immune cells, and different subtypes of epilepsy: A Mendelian randomization study.
Article in Epilepsia open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThe gut microbiota (GM) plays a role in epilepsy development via the microbiota-gut-brain axis. However, its relationship with various epilepsy subtypes and its mediating role through immune cells remain unclear. Thus, identifying the GM linked to specific epilepsy subtypes and investigating immune mechanisms to predict epilepsy risk, tailor treatments, and monitor outcomes are crucial.
methodsWe performed a two-sample Mendelian randomization (MR) study focused on the relationships between different epilepsy subtypes associated with the GM and the mediating role of immune cells between different epilepsy subtypes and the GM. Genome-wide association analysis summary statistics of 412 GM species (GCST90027446-GCST90027857) and 731 immune cell phenotypes (GCST90001391-GCST90002121), along with summary statistics of different subtypes of epilepsy, were used in a publicly available genome-wide association analysis. Significantly associated single-nucleotide polymorphism (SNP) loci were extracted as instrumental variables according to preset thresholds, with an inverse variance weighted (IVW) model being the main model. Additionally, MR-Egger regression, weighted median, weighted, and simple models were also used for analysis.
resultsMR analyses revealed the relationships of the GM and immune cells with diverse epilepsy subtypes, with no statistically significant effect of different epilepsy subtypes on the GM after correction for multiple testing via the false discovery rate (FDR) approach. Notably, one bacterial species, Gordonibacter pamelaeae, with an uncorrected low p-value (OR: 1.0136, 95% CI: 1.0048-1.0225, p = 0.0025), was positively related to childhood absence epilepsy (CAE). Among immune cells, CD4+ ACs (OR: 1.0152, 95% CI: 1.0067-1.0238, p = 0.0005) were strongly related to CAE. Additionally, mediated effect analysis revealed that seven types of GM mediate the effects of eight immune cells on epilepsy, with Bacteroides caccae mediating CD33br HLA DR+ CD14dim AC cells producing the greatest effect on generalized epilepsy. SIGNIFICANCE: The above results demonstrate the close association between specific GM and specific immune cells in epilepsy and can be used to inform the treatment of different epilepsy subtypes by modulating the GM and immune cells. PLAIN LANGUAGE SUMMARY: This study investigated the relationships between the gut microbiota and different epilepsy subtypes and the mediating role of immune cells. These findings emphasize that there is a close association between specific gut microbiota and specific immune cells in epilepsy and that they can be used to inform the treatment of different epilepsy subtypes by modulating the gut microbiota and immune cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.